Table 3.
Histologic changes associated with SARS-CoV
| Tissue | Diagnosis | Group | 1 | 2 | 3 | 4 | 5 | 6 | Control | Control |
|---|---|---|---|---|---|---|---|---|---|---|
| Sacrifice day | 2 | 2 | 5 | 5 | 19 | 19 | 19 | 19 | ||
| Virus | + | + | + | + | + | + | − | − | ||
| CP-D | − | + | − | + | − | + | − | + | ||
| Severity | ||||||||||
| Heart | Number examined | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| No significant lesions | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | ||
| Inflammation, subacute | Minimal | 2 | ||||||||
| Kidney | Number examined | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | |
| No significant lesions | 2 | 0 | 2 | 2 | ||||||
| Dilation, tubular | Mild | 1 | ||||||||
| Degeneration/necrosis, tubular | Mild | 1 | ||||||||
| Lung | Number examined | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| No significant lesions | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 2 | ||
| Inflammation, subacute | Minimal | 2 | 1 | 1 | 2 | |||||
| Pneumonia, bronchointerstitial | Mild | 1 | ||||||||
| Moderate | 2 | 1 | 1 | |||||||
| Nasal turbinate | Number examined | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| No significant lesions | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 2 | ||
| Exudate, fibrinopurulent | Minimal | 1 | ||||||||
| Mild | 1 | 1 | 1 | 1 | ||||||
| Moderate | 2 | 1 | 1 | 1 |